HALB 0.01 Halberd Corporation
| Range: | 0.003-0.0121 | Vol Avg: | 963485 | Last Div: | 0 | Changes: | 0 |
| Beta: | -4.07 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Sep 25 2012 | Empoloyees: | 3 | ||
| CUSIP: | 405331109 | CIK: | 0001458631 | ISIN: | US4053311092 | Country: | US |
| CEO: | Mr. William A. Hartman | Website: | https://halberdcorporation.com | ||||
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow